Hermione Therapeutics showcases ANP’s anti-biofilm potential at AMR 2026

Hermione Therapeutics has been selected to present poster “Development of the Atrial Natriuretic Peptide as a new powerful drug against Pseudomonas aeruginosa and Staphylococcus aureus resistant strain biofilms: its mechanism of action and therapeutic potential” during international conference on antimicrobial…